NZ241496A - Melanocyte stimulating hormone derivatives and pharmaceutical composition - Google Patents
Melanocyte stimulating hormone derivatives and pharmaceutical compositionInfo
- Publication number
- NZ241496A NZ241496A NZ241496A NZ24149692A NZ241496A NZ 241496 A NZ241496 A NZ 241496A NZ 241496 A NZ241496 A NZ 241496A NZ 24149692 A NZ24149692 A NZ 24149692A NZ 241496 A NZ241496 A NZ 241496A
- Authority
- NZ
- New Zealand
- Prior art keywords
- group
- formula
- peptide
- compound
- msh
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/086—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being alphaMSH, alpha melanocyte stimulating hormone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919102450A GB9102450D0 (en) | 1991-02-05 | 1991-02-05 | Improvements in or relating to organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ241496A true NZ241496A (en) | 1994-09-27 |
Family
ID=10689561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ241496A NZ241496A (en) | 1991-02-05 | 1992-02-03 | Melanocyte stimulating hormone derivatives and pharmaceutical composition |
Country Status (11)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5650134A (en) * | 1993-01-12 | 1997-07-22 | Novartis Ag (Formerly Sandoz Ltd.) | Peptides |
| US6174530B1 (en) | 1993-05-05 | 2001-01-16 | Gryphon Sciences | Homogeneous polyoxime compositions and their preparation by parallel assembly |
| US6001364A (en) * | 1993-05-05 | 1999-12-14 | Gryphon Sciences | Hetero-polyoxime compounds and their preparation by parallel assembly |
| EP0697891B1 (en) | 1993-05-05 | 2000-03-29 | Keith Rose | Polyoxime compounds and their preparation |
| KR100999044B1 (ko) | 2008-03-26 | 2010-12-09 | 한국원자력연구원 | 킬레이트제 접합 α-ＭＳＨ 펩타이드 유도체, 이의제조방법 및 이를 유효성분으로 함유하는 흑색종 진단 및치료용 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE109793T1 (de) * | 1987-05-22 | 1994-08-15 | University Patents Inc | Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung. |
| WO1990003798A2 (en) * | 1988-10-04 | 1990-04-19 | Cancer Research Campaign Technology Limited | Targetting agents |
| NZ234173A (en) * | 1989-06-23 | 1993-10-26 | Cancer Res Campaign Tech | Alpha-melanocyte stimulating hormone derivative (alphamsh)-targetted moiety conjugate |
-
1991
- 1991-02-05 GB GB919102450A patent/GB9102450D0/en active Pending
-
1992
- 1992-02-03 NZ NZ241496A patent/NZ241496A/en unknown
- 1992-02-03 IL IL100853A patent/IL100853A0/xx unknown
- 1992-02-03 CA CA002060537A patent/CA2060537A1/en not_active Abandoned
- 1992-02-03 AU AU10653/92A patent/AU1065392A/en not_active Abandoned
- 1992-02-03 FI FI920456A patent/FI920456L/fi not_active Application Discontinuation
- 1992-02-03 EP EP19920810072 patent/EP0498771A3/en not_active Withdrawn
- 1992-02-04 IE IE035792A patent/IE920357A1/en unknown
- 1992-02-04 JP JP4018811A patent/JPH04347000A/ja active Pending
- 1992-02-05 ZA ZA92827A patent/ZA92827B/xx unknown
- 1992-02-10 TW TW081100879A patent/TW221296B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04347000A (ja) | 1992-12-02 |
| EP0498771A3 (en) | 1992-11-25 |
| FI920456A7 (fi) | 1992-08-06 |
| TW221296B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1994-02-21 |
| GB9102450D0 (en) | 1991-03-20 |
| FI920456L (fi) | 1992-08-06 |
| AU1065392A (en) | 1992-08-13 |
| IL100853A0 (en) | 1992-11-15 |
| ZA92827B (en) | 1993-08-05 |
| IE920357A1 (en) | 1992-08-12 |
| FI920456A0 (fi) | 1992-02-03 |
| EP0498771A2 (en) | 1992-08-12 |
| CA2060537A1 (en) | 1993-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3686503B2 (ja) | ペプチド誘導体 | |
| EP0785951B1 (en) | Tc or re radiolabelled somatostatin analogs | |
| EP2790732B1 (en) | Clicked somatostatin conjugated analogs for biological applications | |
| EP1872800B1 (en) | Radiolabeled peptide compositions for site-specific targeting | |
| JP3397338B2 (ja) | ポリペプチド類 | |
| JP2000515514A (ja) | 放射性金属元素結合ペプチドの類似化合物 | |
| US5776894A (en) | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors | |
| US5753627A (en) | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis | |
| JP2025507971A (ja) | 前立腺特異的膜抗原を標的とする放射性標識化合物 | |
| CA2232196A1 (en) | A method for preparing radiolabeled peptides | |
| NZ241496A (en) | Melanocyte stimulating hormone derivatives and pharmaceutical composition | |
| EP0785928A1 (en) | NOVEL N3 S2 CHELATING LIGANDS OPTIONALLY RADIOLABELLED WITH Tc OR Re, USEFUL FOR DIAGNOSTIC OR THERAPEUTIC APPLICATIONS | |
| US5736120A (en) | Method for preparing radiolabeled peptides | |
| CY1893A (en) | Detectable somatostatin analogues containing a chelating group |